Aprea Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- 7
- Market Cap
- $19.1M
- Website
- http://www.aprea.com
- Introduction
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva,...
Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA-119 Clinical
Aprea Therapeutics announced the first patient dosed with ATRN-119 550 mg twice daily in the ABOYA-119 Phase 1/2a trial, aiming to optimize therapeutic levels and enhance efficacy. This strategic adjustment is expected to improve clinical outcomes and accelerate the path to regulatory approval and commercialization.
Related Clinical Trials:
Aprea Therapeutics Advances Novel Cancer Drug Trial with Breakthrough Dosing Strategy
Aprea Therapeutics initiates twice daily (BID) 550mg dosing in ABOYA-119 Phase 1/2a trial of ATRN-119, aiming to maintain optimal therapeutic levels, enhance efficacy, and accelerate regulatory approval. The trial evaluates ATRN-119 as monotherapy in advanced solid tumors with DNA damage response gene mutations, with Phase 1 results expected in H2 2025.
Related Clinical Trials:
Aprea Therapeutics Reports Q3 Financials and Advances in Clinical Trials
Aprea Therapeutics reports Q3 2024 financials, highlighting progress in WEE1 inhibitor APR-1051 and ATR inhibitor ATRN-119 trials. Dr. Philippe Pultar joins as senior medical advisor. Cash reserves of $26.2 million support operations for at least 12 months, with a net loss of $3.8 million. R&D expenses increased to $2.8 million, while G&A costs decreased to $1.6 million.
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President
Halda Therapeutics appoints Christian Schade as CEO, aiming to advance RIPTAC™ therapeutics for cancer treatment.
© Copyright 2024. All Rights Reserved by MedPath